<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03453242</url>
  </required_header>
  <id_info>
    <org_study_id>K 171006J</org_study_id>
    <nct_id>NCT03453242</nct_id>
  </id_info>
  <brief_title>Age Influence on Cortical Bone Measured by Ultrasound</brief_title>
  <acronym>OCO-US</acronym>
  <official_title>Age Influence on Cortical Bone Measured by Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study of this study is to evaluate the age influence on cortical bone strength properties&#xD;
      by two methods:HR-pQCT (HighResolution-peripheral quantitativeComputedTomography) and&#xD;
      ultrasound. The main objective consists in the evaluation of the age influence on cortical&#xD;
      thickness at 1/3 distal radius measured by US.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study of this study is to evaluate the age influence on cortical bone by two methods:&#xD;
      HR-pQCT and ultrasound.&#xD;
&#xD;
      84 patients will be measured. The cohort will be:&#xD;
&#xD;
        -  21 women less than 70&#xD;
&#xD;
        -  21 women more than 70&#xD;
&#xD;
        -  21 men less than 70&#xD;
&#xD;
        -  21 men more than 70 Measurement will be performed at radius and at tibia (ultra-distal&#xD;
           and distal). For all the sites one measurement will be performed by HR-pQCT to get&#xD;
           reference values of thickness and BMDs. For the distal positions and additional&#xD;
           measurement will be performed by an innovative ultrasound device that estimates cortical&#xD;
           thickness and porosity.&#xD;
&#xD;
      The participation to the study implies only a participation of one hour from the patient&#xD;
      (30min for HR-pQCT measurements, 30 min for US).&#xD;
&#xD;
      The main objectives consist in :&#xD;
&#xD;
        -  evaluating the age influence on cortical thickness at 1/3 distal radius measured by US&#xD;
&#xD;
        -  evaluating the age influence on cortical thickness at distal tibia measured by US&#xD;
&#xD;
        -  comparing porosities values measured by US to vBMD obtained by HR-pQCT&#xD;
&#xD;
        -  comparing cortical thickness values measured by HR-pQCT at 1/3 distal radius position to&#xD;
           ultra-distal radus position and to the tibia&#xD;
&#xD;
        -  comparing vBMD values measured by HRpQCT at 1/3 distal radius position to ultra-distal&#xD;
           radius position and to the tibia&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty of recruitment due to COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">March 2, 2018</start_date>
  <completion_date type="Actual">July 19, 2019</completion_date>
  <primary_completion_date type="Actual">July 19, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Cortical parameters measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Cortical thickness at distal radius 1/3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tibia parameters measurement by US</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Cortical thickness distal 1/2 tibia obtained by US&#xD;
ultra-distal and 1/3 distal cortical thicknesses obtained by HR-pQCT&#xD;
ultra-distal and 1/3 distal vBMD obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tibia parameters measurement by HR-pQCT</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Cortical thickness distal 1/2 tibia obtained by HR-pQCT&#xD;
ultra-distal and 1/3 distal cortical thicknesses obtained by HR-pQCT&#xD;
ultra-distal and 1/3 distal vBMD obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Porosity measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Ultrasonic porosity obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vBMD measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>vBMD obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortical parameters measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>1/3 distal cortical thicknesses obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thicknesses measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Ultra-distal thicknesses obtained by HR-pQCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultra-distal vBMD measurement</measure>
    <time_frame>Inclusion time</time_frame>
    <description>Ultra-distal vBMD and third distal obtained by HR-pQCT</description>
  </secondary_outcome>
  <enrollment type="Actual">66</enrollment>
  <condition>Cortical Bone Erosion</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bone measurement by HR-pQCT and ultrasound</intervention_name>
    <description>Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites one measurement will be performed by HR-pQCT to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The cohort will be:&#xD;
&#xD;
        Women and men less than 70 Women and men more than 70&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  being 18 or older&#xD;
&#xD;
          -  coming from the rheumatology consultation at Lariboisière Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 28&#xD;
&#xD;
          -  BMI &lt; 15&#xD;
&#xD;
          -  cortisone treatment&#xD;
&#xD;
          -  recent fracture at non-dominant arm&#xD;
&#xD;
          -  wound on measuring zone&#xD;
&#xD;
          -  treatment interfering with bone architecture or bone density : oral of transdermic&#xD;
             oestrogenes, bisphosphonates (Alendronate, Risedronate, Zoledronate) or Denosumab&#xD;
             during the past 6 months-&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cohen-Solal Martine, Martine</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cohen-Solal</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Barkmann R, Kantorovich E, Singal C, Hans D, Genant HK, Heller M, Glüer CC. A new method for quantitative ultrasound measurements at multiple skeletal sites: first results of precision and fracture discrimination. J Clin Densitom. 2000 Spring;3(1):1-7.</citation>
    <PMID>10745297</PMID>
  </reference>
  <reference>
    <citation>Bochud N, Vallet Q, Bala Y, Follet H, Minonzio JG, Laugier P. Genetic algorithms-based inversion of multimode guided waves for cortical bone characterization. Phys Med Biol. 2016 Oct 7;61(19):6953-6974. Epub 2016 Sep 12.</citation>
    <PMID>27617648</PMID>
  </reference>
  <reference>
    <citation>Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010 May 15;375(9727):1729-36. doi: 10.1016/S0140-6736(10)60320-0.</citation>
    <PMID>20472174</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoporosis</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

